Related Experiment Video
Updated: May 5, 2026
12:17
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
Published on: May 8, 2017
11.4K
Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis
Elias B Chahine1, Lamis R Karaoui, Hanine Mansour
1Palm Beach Atlantic University, West Palm Beach, FL, USA.
The Annals of Pharmacotherapy
|November 22, 2013
Summary
Bedaquiline is a new oral medication for multidrug-resistant tuberculosis (MDR-TB). It shows strong activity but has safety concerns, including mortality and QT prolongation risks, requiring careful administration.
Area of Science:
- Pharmacology and Microbiology
- Clinical Medicine
Background:
- Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health challenge.
- Existing treatment regimens for MDR-TB have suboptimal efficacy and toxicity.
- Emerging resistance necessitates novel therapeutic agents.
Purpose of the Study:
- To provide a comprehensive review of bedaquiline, a novel antimycobacterial agent.
- To evaluate the chemistry, pharmacology, microbiology, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, dosage, and administration of bedaquiline.
- To assess bedaquiline's role in treating pulmonary multidrug-resistant tuberculosis (MDR-TB).
Main Methods:
- Literature search of PubMed and International Pharmaceutical Abstracts (2004-2013).
- Inclusion of supplementary data from the Union World Conference on Lung Health proceedings.
- Evaluation of preclinical data and Phase 1 and 2 clinical studies.
Main Results:
- Bedaquiline exhibits a unique mechanism of action targeting mycobacterial adenosine triphosphate synthase.
- Demonstrates excellent in vitro activity against Mycobacterium tuberculosis, including MDR strains.
- Clinical trials show efficacy in combination regimens for MDR-TB, but side effect profile necessitates cautious use.
- Bedaquiline is metabolized by CYP3A4, leading to potential drug interactions.
Conclusions:
- Bedaquiline is a valuable addition to the anti-TB armamentarium, especially for MDR-TB.
- Its unique mechanism and efficacy are crucial in combating resistant strains.
- Careful consideration of its safety profile, including Black Box warnings for mortality and QT prolongation, is essential for optimal patient outcomes.
Related Concept Videos
01:28Pulmonary Tuberculosis V
1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
01:15Anthelminthic Agents
115
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
115
01:31Pulmonary Tuberculosis III
1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
01:28Inhibitors of Bacterial DNA Synthesis
151
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
151
01:26Pulmonary Tuberculosis IV
844
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
844